Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension (BETTER-HTN)

NCT00913094 is registered in ClinicalTrials.gov with CardioDynamics as lead sponsor.

NCT NCT00913094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00913094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension (BETTER-HTN)
Lead sponsor
CardioDynamics
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2009
Completion date
June 30, 2011
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension